Formats
PDF report
Free
666kB
Another format
If you need this publication in an alternative format, please contact us.
Medication use for ankylosing spondylitis, psoriatic arthritis, and juvenile arthritis 2016–17
Publication
Release Date:
Topic: Musculoskeletal conditions
Citation
AIHW (Australian Institute of Health and Welfare) (2019) Medication use for ankylosing spondylitis, psoriatic arthritis, and juvenile arthritis 2016–17, AIHW, Australian Government, accessed 26 June 2026.
PDF | 666kB
This report examines the prescription patterns for medications specific to 3 musculoskeletal conditions: ankylosing spondylitis, psoriatic arthritis and juvenile arthritis. In 2016–17, 225,000 medications specific to the treatment of either ankylosing spondylitis or psoriatic arthritis were dispensed. Analysis of de-identified unit record PBS data produced an estimate of up to 5,400 children living with juvenile arthritis in 2016–17, who were prescribed medication from the PBS.
- ISBN: 978-1-76054-612-0 (Online)
- Cat. no: PHE 262
- Pages: 36